Related Experiment Video
Updated: Apr 23, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver
Dong Liu1, Linxue Qian1, Jinrui Wang2
1Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Contrast-enhanced ultrasonography (CEUS) reveals liver parenchyma blood supply ratios that correlate with chronic liver disease severity. These parameters, including a new liver parenchyma blood supply ratio, show potential for non-invasive assessment of cirrhosis.
Area of Science:
- Hepatology and diagnostic imaging.
- Utilizing advanced ultrasound techniques for liver disease assessment.
Background:
- Chronic liver disease and cirrhosis significantly alter liver perfusion.
- Current methods for assessing disease severity can be invasive.
Purpose of the Study:
- To investigate the correlation between liver parenchyma perfusion parameters obtained via contrast-enhanced ultrasonography (CEUS) and the severity of chronic liver disease.
- To evaluate a novel liver parenchyma blood supply ratio for differentiating arterial and portal phases.
Main Methods:
- CEUS examination of 12 patients with non-cirrhotic chronic liver disease, 35 with cirrhosis, and 21 healthy volunteers.
- Analysis of time-intensity curves from liver parenchyma and kidney cortex using QLAB software.
- Quantification of hepatic arterial flow intensity (I(ap)), peak perfusion intensity (I(peak)), portal venous flow intensity (I(pp)), and the ratio I(pp)/I(peak).
Main Results:
- Liver parenchyma perfusion parameters (I(pp), I(peak), I(pp)/I(peak)) significantly decreased in patients with chronic liver disease and cirrhosis, while I(ap) increased.
- Strong correlations were found between I(pp), I(peak), I(pp)/I(peak), and I(ap) with chronic liver disease severity (p < 0.05).
- High diagnostic accuracy for cirrhosis was achieved with I(peak) (0.93), I(pp) (0.98), and I(pp)/I(peak) (0.98).
Conclusions:
- CEUS-derived liver parenchyma perfusion parameters are significantly correlated with the severity of chronic liver disease.
- The novel liver parenchyma blood supply ratio and other perfusion parameters show promise for non-invasive assessment and diagnosis of cirrhosis.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

